---
$id: https://graph.org.ai/products/commodity/51151514
$type: Product
source: UNSPSC
code: "51151514"
title: "Pyridostigmine"
class: "51151500"
classTitle: "Cholinergic drugs and cholinesterase inhibitors"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Pyridostigmine

**UNSPSC Code**: 51151514
**Class**: [Cholinergic drugs and cholinesterase inhibitors](Cholinergic drugs and cholinesterase inhibitors.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an acetylcholinesterase inhibitor with the molecular formula C9H13N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 19QM69HH21, chemically known as pyridinium, 3-hydroxy-1-methyl-, dimethylcarbamate (ester) but generally known as pyridostigmine, which bears US NIH Compound Identifier 4991. European Medicines Agency schedules Pyridostigmine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB15059MIG. World Health Organization schedules pyridostigmine in its Anatomical Therapeutic Chemical (ATC) Classification. PYRIDOSTIGMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, PYRIDOSTIGMINE remains the US FDA Preferred Term for this commodity. Pyridostigmine bears US NLM identifiers UMLS ID C0034261 and NCI Concept Code C76139. SMILES: O(C1C[N](CCC1)C)C(=O)N(C)C.

